文献检索/Expert Opinion on Drug SafetyEM-T3Expert Opinion on Drug Safety2024-03-12第 23 卷第 4 期，477-486开放获取A comprehensive analysis of liver safety across zibotentan oncology trials: knowledge of the past offers new perspectives on the presentAnna FettiplaceAstraZeneca (United Kingdom)Sherri Matis‐MitchellAstraZeneca (United States)Oleksandr MolodetskyiAstraZeneca (Sweden)Malin SöderberghAstraZeneca (Sweden)Jan OscarssonAstraZeneca (Sweden)Min LinAstraZeneca (United States)Srivathsa RavikiranAstraZeneca (United States)Martin A. BillgerAstraZeneca (Sweden)Phil AmberyAstraZeneca (Sweden)去出版社页面 引用论文图谱收藏 被引提醒分享打印登录后看摘要和中文要点英文摘要、AI 生成的中文摘要和三条要点、参考文献和引证文献列表、论文图谱，注册免费。登录 / 注册关键词zibotentanendothelin receptor antagonistshepatotoxicitydrug-induced liver injuryliver safetycancer clinical trialsALT elevationHy's lawdapagliflozinchronic kidney diseaseliver cirrhosisliver biochemistry参考文献31引证文献0相似文献引文网络关联作者相关机构登录后可以看完整列表。去登录论文图谱本篇和它的参考文献、引证文献、相似文献登录后可以看这篇的论文图谱：谁被它引用、谁引用了它、还有哪些相似的研究。登录 / 注册
